𝔖 Bobbio Scriptorium
✦   LIBER   ✦

A Phase II Trial of Neoadjuvant Gemcitabine, Epirubicin, and Docetaxel as Primary Treatment of Patients With Locally Advanced or Inflammatory Breast Cancer

✍ Scribed by Denise A. Yardley; Nancy W. Peacock; Natalie R. Dickson; Melissa B. White; Elizabeth R. Vázquez; John T. Foust; Richard Grapski; Linda K. Hendricks; William L. Scott; John D. Hainsworth


Book ID
115075867
Publisher
CIG Media Group, LP.
Year
2010
Tongue
English
Weight
609 KB
Volume
10
Category
Article
ISSN
1526-8209

No coin nor oath required. For personal study only.


📜 SIMILAR VOLUMES